The current stock price of NNOX is 3.64 USD. In the past month the price increased by 15.56%. In the past year, price decreased by -54.33%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.04 | 96.01B | ||
| CI | THE CIGNA GROUP | 9.34 | 70.91B | ||
| LH | LABCORP HOLDINGS INC | 16.33 | 21.42B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 118.23 | 21.75B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.7 | 20.30B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.14B | ||
| HIMS | HIMS & HERS HEALTH INC | 72.59 | 8.92B | ||
| DVA | DAVITA INC | 12.72 | 8.29B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 35.09 | 6.45B | ||
| RDNT | RADNET INC | 206.82 | 6.06B | ||
| CHE | CHEMED CORP | 19.18 | 5.98B | ||
| OPCH | OPTION CARE HEALTH INC | 20.06 | 4.74B |
Nano-X Imaging Ltd. engages in the development of medical imaging systems.
NANO-X IMAGING LTD
Ofer Tech Park, 94 Shlomo Shmeltzer Road
Petah Tikva 9085000 IL
CEO: Ran Poliakine
Employees: 165
Phone: 97237359202
Nano-X Imaging Ltd. engages in the development of medical imaging systems.
The current stock price of NNOX is 3.64 USD. The price decreased by -4.96% in the last trading session.
NNOX does not pay a dividend.
NNOX has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
10 analysts have analysed NNOX and the average price target is 7.91 USD. This implies a price increase of 117.17% is expected in the next year compared to the current price of 3.64.
NANO-X IMAGING LTD (NNOX) operates in the Health Care sector and the Health Care Providers & Services industry.
The outstanding short interest for NANO-X IMAGING LTD (NNOX) is 12.39% of its float.
ChartMill assigns a technical rating of 3 / 10 to NNOX. When comparing the yearly performance of all stocks, NNOX is a bad performer in the overall market: 88.71% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to NNOX. NNOX has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months NNOX reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS decreased by -14.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.64% | ||
| ROE | -35.55% | ||
| Debt/Equity | 0 |
10 analysts have analysed NNOX and the average price target is 7.91 USD. This implies a price increase of 117.17% is expected in the next year compared to the current price of 3.64.
For the next year, analysts expect an EPS growth of -9.46% and a revenue growth 12.16% for NNOX